Maravai Lifesciences Holdings (MRVI) FCF Margin (2020 - 2026)

Maravai Lifesciences Holdings' FCF Margin history runs 7 years deep, the most recent figure standing at 6.42% for Q1 2026.

• In Q1 2026, FCF Margin rose 2953.0% year-over-year to 6.42%; the TTM figure through Mar 2026 stood at 27.19% (down 1835.0% YoY), while the FY2025 annual figure was 38.08%, down 2951.0% from the prior year.
• FCF Margin was 6.42% for Q1 2026 at Maravai Lifesciences Holdings, up from 70.19% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 97.7% in Q1 2023 to a low of 70.19% in Q4 2025.
• Historically, FCF Margin has averaged 7.17% across 5 years, with a median of 6.42% in 2026.
• Biggest YoY gain for FCF Margin was 5418 bps in 2024; the steepest drop was 11582 bps in 2024.
• A 5-year view of FCF Margin shows it stood at 41.05% in 2022, then tumbled by 130 bps to 12.15% in 2023, then tumbled by 198 bps to 36.22% in 2024, then tumbled by 94 bps to 70.19% in 2025, then jumped by 109 bps to 6.42% in 2026.
• The last three FCF Margin figures came in at 6.42% (Q1 2026), 70.19% (Q4 2025), and 34.46% (Q3 2025), per Business Quant data.